Studies on duocarmycin SA and its derivatives

Bioorganic and Medicinal Chemistry

Volumn 5, Issue 3, 1997, Pages 623-630

  Nagamura, Satoru ^a   Asai, Akira ^a   Kobayashi, Eiji ^a   Gomi, Katsushige ^a   Saito, Hiromitsu ^a  

^a KYOWA HAKKO KOGYO CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DUOCARMYCIN A; DUOCARMYCIN SA; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG SYNTHESIS; HELA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; SARCOMA 180; STRUCTURE ACTIVITY RELATION;

EID: 0031106242     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(96)00276-3     Document Type: Article

References (56)

1. 1. (a) Ichimura, M.; Ogawa, T.; Takahashi, K.; Kobayashi, E.; Kawamoto, I.; Yasuzawa, T.; Takahashi, I.; Nakano, H. J. Antibiot. 1990, 43, 1037.
2. (b) Yasuzawa, T.; Saitoh, Y.; Ichimura, M.; Takahashi, I.; Sano, H. J. Antibiot. 1991, 44, 445.
3. 2. (a) Takahashi, I.; Takahashi, K.; Ichimura, M.; Morimoto, M.; Asano, K.; Kawamoto, I.; Tomita, F.; Nakano, H. J. Antibiot. 1988, 41, 1915.
4. (b) Yasuzawa, T.; Iida, T.; Muroi, K.; Ichimura, M.; Takahashi, K.; Sano, H. Chem. Pharm. Bull. 1988, 36, 3728.
5. (c) Ichimura, M.; Muroi, K.; Asano, K.; Kawamoto, I.; Tomita, F.; Morimoto, M.; Nakano, H. J. Antibiot. 1988, 41, 1285.
6. (d) Ogawa, T.; Ichimura, M.; Katsumata, S.; Morimoto, M.; Takahashi, K. J. Antibiot. 1989, 42, 1299.
7. (e) Ichimura, M.; Ogawa, T.; Katsumata, S.; Takahashi, K.; Takahashi, I.; Nakano, H. J. Antibiot. 1991, 44, 1045.
8. (f) Yasuzawa, T.; Muroi, K.; Ichimura, M.; Takahashi, I.; Ogawa, T.; Takahashi, K.; Sano, H.; Saitoh, Y. Chem. Pharm. Bull. 1995, 43, 378.
9. (g) Ohba, K.; Watabe, H.; Sasaki T.; Takeuchi, Y.; Kodama, Y.; Nakazawa, T.; Yamamoto, H.; Shomura, T.; Sezaki, M.; Kondo, S. J. Antibiot. 1988, 41, 1515.
10. (h) Ishii, S.; Nagasawa, M.; Kariya, Y.; Yamamoto, H.; Inoue, S.; Kondo, S. J. Antibiot. 1989, 42, 1713.
11. 3. (a) Hanka, L. J.; Dietz, A.; Gerpheide, S. A.; Kuentzel, S. L.; Martin, D. G. J. Antibiot. 1978, 37, 1211.
12. (b) Martin, D. G.; Chidester, C. G.; Duchamp, D. J.; Mizsak S. A. J. Antibiot. 1980, 33, 902.
13. (c) Reynolds, V. L.; McGovren, J. P.; Hurley, L. H. J. Antibiot. 1986, 39, 319.
14. (d) Hurley, L. H.; Reynolds, V. L.; Swenson, D. H.; Petzold, G. L.; Scahill, T. A. Science 1984, 226, 843.
15. (e) Raynolds, V. L.; Molineaux, I. J.; Kaplan, D. J.; Swensen, D. H.; Hurley, L. H. Biochemistry 1985, 24, 6228.
16. (f) Tang, M. S.; Lee, C. S.; Doisy, R.; Ross, L.; Needham-Van Devanter, D. R.; Hurley, L. H. Biochemistry 1988, 27, 893.
17. 4. (a) Boger, D. L.; Ishizaki, T.; Zarrinmayeh, H. J. Org. Chem. 1990, 55, 4499.
18. (b) Sugiyama, H.; Hosoda, M.; Saito, I.; Asai, A.; Saito, H. Tetrahedron Lett. 1990, 31, 7197.
19. (c) Boger, D. L.; Ishizaki, T.; Zarrinmayeh, H.; Munk, S. A.; Kitos, P. A.; Suntornwat, O. J. Am. Chem. Soc. 1990, 112, 8961.
20. (d) Boger, D. L.; Ishizaki, T.; Zarrinmayeh, H. J. Am. Chem. Soc. 1991, 113, 6645.
21. (e) Sugiyama, H.; Ohmori, K.; Chan, K. L.; Hosoda, M.; Asai, A.; Saito, H.; Saito, I. Tetrahedron Lett. 1993, 34, 2179.
22. (f) Boger, D. L.; Johnson, D. S.; Yun, W. J. Am. Chem. Soc. 1994, 116, 1635.
23. 5. Ichimura, M.; Ogawa, T.; Takahashi, K.; Mihara, A.; Takahashi, I.; Nakano, H. Oncol. Res. 1993, 5, 165.
24. 6. (a) Boger, D. L.; Machiya, K. J. Am. Chem. Soc. 1992, 114, 10056.
25. (b) Boger, D. L.; Machiya, K.; Hertzog, D. L.; Kitos, P. A.; Holmes, D. J. Am. Chem. Soc. 1993, 115, 9025.
26. (c) Muratake, H.; Matsumura, N.; Natsume, M. Chem. Pharm. Bull. 1995, 43, 1064.
27. (d) Boger, D. L.; Yun, W.; Han, N. Bioorg. Med. Chem. 1995, 3, 1429.
28. (e) Muratake, H.; Abe, I.; Natsume, M. Chem. Pharm. Bull. 1996, 44, 67.
29. (f) Boger, D. L.; Goldberg, J.; McKie, J. A. Bioorg. Med. Chem. Lett. 1996, 6, 1955.
30. (g) Boger, D. L.; Bollinger, B.; Johnson, D. S. Bioorg. Med. Chem. Lett. 1996, 6, 2207.
31. 7. (a) Gomi, K.; Kobayashi, E.; Miyoshi, K.; Ashizawa, T.; Okamoto, A.; Ogawa, T.; Katsumata, S.; Mihara, A.; Okabe, M.; Hirata, T. Jpn. J. Cancer Res. 1992, 83, 113.
32. (b) Nagamura, S.; Kanda, Y.; Kobayashi, E.; Gomi, K.; Saito, H. Chem. Pharm. Bull. 1995, 43, 1530.
33. 8. (a) Nagamura, S.; Asai, A.; Kanda, Y.; Kobayashi, E.; Gomi, K.; Saito, H. Chem. Pharm. Bull. 1996, 44, 1723.
34. (b) Kobayashi, E.; Okamoto, A.; Asada, M.; Okabe, M.; Nagamura, S.; Asai, A.; Saito, H.; Gomi, K.; Hirata, T. Cancer Res. 1994, 54, 2404.
35. (c) Asai, A.; Nagamura, S.; Saito, H. J. Am. Chem. Soc. 1994, 116, 4171.
36. 9. (a) Nagamura, S.; Kanda, Y.; Asai, A.; Kobayashi, E.; Gomi, K.; Saito, H. Chem. Pharm. Bull. 1996, 44, 933.
37. (b) Berner, D.; Cox, D. P.; Dahn, H. J. Am. Chem. Soc. 1982, 104, 2631.
38. 10. Nagamura, S.; Kobayashi, E.; Gomi, K.; Saito, H. Bioorg. Med. Chem. 1996, 4, 1379.
39. 11. Asai, A.; Nagamura, S.; Kobayashi, E.; Gomi, K.; Saito, H. Bioorg. Med. Chem. Lett. 1996, 6, 1215.
40. 12. Mukaiyama, T.; Usui, M.; Shimada, E.; Saigo, K. Chem. Lett. 1975, 1045.
41. 13. (a) The biological activities of other functional moieties except alkoxy groups were examined, but we could not find the good functional group superior to the alkoxy group (J. Med. Chem. 1997 40, in press).
42. (b) The reduced intracellular permeability by charged molecules in this series has been previously discussed. Boger, D. L.; Yun, W.; Han, N.; Johnson, D. S. Bioorg. Med. Chem. 1995, 3, 611.
43. 14. (a) Hansen, J.; Mork, N.; Bundgaard, H. Int. J. Pharm. 1992, 81, 253.
44. (b) Heymann, E. Metabolic Basis of Detoxification; Jakoby, W. B.; Bend, J. R.; Caldwell, J., Eds.; Academic Press: New York, 1982.
45. (c) Ohe, Y.; Sasaki, Y.; Shinkai, T.; Eguchi, K.; Tamura, T.; Kojima, A.; Kunikane, H.; Okamoto, H.; Karato, A.; Ohmatsu, H.; Kanzawa, F.; Saijo, N. J. Natl. Cancer Inst. 1992, 84, 972.
46. 15. (a) Ogasawara, H.; Nishio, K.; Takeda, Y.; Ohmori, T.; Kubota, N.; Funayama, Y.; Ohira, T.; Kuraishi, Y.; Isogai, Y.; Saijo, N. Jpn. J. Cancer Res. 1994, 85, 418.
47. (b) Okamoto, A.; Asai, A.; Saito, H.; Okabe, M.; Gomi, K. Jpn. J. Cancer Res. 1994, 85, 1304.
48. (c) Ogasawara, H.; Nishio, K.; Kanzawa, F.; Lee, Y.-S.; Funayama, Y.; Ohira, T.; Kuraishi, Y.; Isogai, Y.; Saijo, N. Jpn. J. Cancer Res. 1995, 86, 124.
49. 16. (a) Boger, D. L.; Yun, W. J. Am. Chem. Soc. 1994, 116, 5523.
50. (b) Boger, D. L. Acc. Chem. Res. 1995, 28, 20.
51. (c) Boger, D. L.; Mesini, P. J. Am. Chem. Soc. 1995, 117, 11647.
52. (c) Boger, D. L.; McKie, J. A.; Han, N.; Tarby, C. M.; Riggs, H. W.; Kitos, P. A. Bioorg. Med. Chem. Lett. 1996, 6, 659.
53. (d) Boger, D. L.; Han, N.; Tarby, C. M.; Boyce, C. W.; Cai, H.; Jin, Q.; Kitos, P. A. J. Org. Chem. 1996, 61, 4894.
54. 17. Nagamura, S.; Kobayashi, E.; Gomi, K.; Saito, H. Bioorg. Med. Chem. Lett. 1996, 6, 2147.
55. 18. Geran, R. I.; Greenberg, N. H.; MacDonald, M. M.; Schumacher, A. M.; Abbott, B. J. Cancer Chemother. Rep. 1972, 3, 1.
56. 19. Inaba, M.; Kobayashi, T.; Tashiro, T.; Sakurai, Y.; Maruo, K.; Ohnishi, Y.; Ueyama, Y.; Nomura, T. Cancer 1989, 64, 1577.